Zoetis
ZTS · NYSE
Bulios Fair Price
$81.97
11.7% upside
Trenutna cena
$73.41
Po podatkih Bulios Fair Price je delnica ZTS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Zoetis Inc. (ZTS) is a global pharmaceutical company focused on animal health, headquartered in the USA. The company specializes in the development, manufacturing, and sale of medications and vaccines for animals. Zoetis provides a wide range of products for animal treatment and disease prevention in both domestic pets and livestock. Their portfolio includes medications for animals such as dogs, cats, cattle, pigs, poultry, and others. With its research, innovations, and global presence, Zoetis has gained a leading position in the field of animal health. The company focuses on improving the quality of life for animals and supports animal health worldwide. Zoetis Inc. (ZTS) shares can be an attractive investment opportunity for investors monitoring the animal health sector and valuing stability and long-term growth in this industry.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kristin C. Peck
Employees
14,500
Headquarters
Parsippany
Prihajajoči dogodki
Earnings
Upcoming earnings report